Enhanced acrylic IOL
Bausch + Lomb has announced the launch of its new INCISE microincision IOL. “This enhanced acrylic IOL, in combination with the capabilities of the Stellaris Vision Enhancement System, allows surgeons to perform microincision cataract surgery less than 2mm, delivering less invasive surgery for a more rapid visual recovery,†said a company spokesman. “The new lens offers a number of features to deliver an enhanced experience for both the surgeon and patient and ultimately better outcomes,†he said. “The INCISE IOL’s aspheric advanced optics are designed to enhance visual quality. The combination of an enhanced acrylic, improved Stellaris system capabilities and a new single use INCISE Viscoject Bioinjector enables 1.8mm in-the-bag and 1.4mm wound assist implantation enabling surgeons to benefit from a controlled sub-2mm MICS procedure,†said the spokesman.
www.bausch.com
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.